This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Geiben-Lynn, R.
Right arrow Articles by Letvin, N. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Geiben-Lynn, R.
Right arrow Articles by Letvin, N. L.

 Previous Article  |  Next Article 

Clinical and Vaccine Immunology, April 2008, p. 691-696, Vol. 15, No. 4
1071-412X/08/$08.00+0     doi:10.1128/CVI.00418-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Kinetics of Recombinant Adenovirus Type 5, Vaccinia Virus, Modified Vaccinia Ankara Virus, and DNA Antigen Expression In Vivo and the Induction of Memory T-Lymphocyte Responses{triangledown}

Ralf Geiben-Lynn,*{dagger} John R. Greenland,{dagger} Kwesi Frimpong-Boateng, and Norman L. Letvin

Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215

Received 16 October 2007/ Returned for modification 14 December 2007/ Accepted 5 February 2008

While a new generation of vaccine vectors has been developed for eliciting cellular immune responses, little is known about the optimal routes for their administration or about the ramifications of the kinetics of in vivo vaccine antigen expression for immunogenicity. We evaluated the kinetics of vaccine antigen expression by real-time in vivo photon imaging and showed dramatic differences in these kinetics using different vectors and different routes of administration. Further, using a gamma interferon enzyme-linked immunospot assay to measure T-lymphocyte immune responses, we observed an association between the kinetics of vaccine antigen expression in vivo and the magnitude of vaccine-elicited memory T-lymphocyte responses. These results highlight the utility of the real-time in vivo photon-imaging technology in evaluating novel immunization strategies and suggest an association between the kinetics of vaccine antigen clearance and the magnitude of vaccine-elicited T-lymphocyte memory immune responses.

* Corresponding author. Mailing address: 41 Avenue Louis Pasteur, Boston, MA 02115. Phone: (617) 667-2083. Fax: (617) 667-8210. E-mail: rgeibenl{at}bidmc.harvard.edu

{triangledown} Published ahead of print on 13 February 2008.

{dagger} R.G.-L. and J.R.G. contributed equally to this work.

Clinical and Vaccine Immunology, April 2008, p. 691-696, Vol. 15, No. 4
1071-412X/08/$08.00+0     doi:10.1128/CVI.00418-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.





Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»